publication date: Dec. 19, 2014

Calvo Named Chief Scientific Officer of Cancer Core Europe

 

FABIEN CALVO was named chief scientific officer of Cancer Core Europe.

Calvo is currently a professor of pharmacology at the University of Paris Denis Diderot Medical School and a physician at Saint Louis Hospital in Paris. He specializes in genomics and the biology of metastatic disease, translational research, preclinical pharmacology and early clinical trials in hematology and oncology.

Previously, from April 2007 to September 2014, Calvo was deputy director general of the National Cancer Institute of France. Calvo was also director of the Cancer Multi-Organization Institute of the National Alliance for Life Sciences and Health, which includes INSERM, CNRS, CEA, INRA, INRIA, IRD, Pasteur Institute, Universities and University hospitals. He also helped launch the International Cancer Genoma Consortium in 2008 and the global alliance for genomics and clinics.

Launched in July, Cancer Core Europe is a consortium comprising of six European cancer centers: the Gustave Roussy Cancer Campus Grand Paris; Cambridge Cancer Research UK Centre; the Karolinska Institutet in Stockholm; the Netherlands Cancer Institute; the Vall d’Hebron Institute of Oncology in Barcelona; and the German Cancer Research Center and its National Center for Tumor Diseases.

 

THE OHIO STATE UNIVERSITY Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute opened in a new hospital building, following a four-phase transition that involved 700 staff and volunteers, spanning three days.

The move began at 6 a.m. Dec. 12 with critical care patients. All other acute care patients were transitioned Dec. 14 during overlapping patient moves that start every six minutes.

Sixteen transport teams … Continue reading 40-47 Calvo Named Chief Scientific Officer of Cancer Core Europe

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.